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IntroductIon
Inflammasomes are large intracellular multiprotein complexes 
that are key players in host defense during innate immune 
responses against pathogen microorganisms, and also in the 
development of inflammatory disorders. Inflammasomes are 
believed to assemble after cellular exposure to pathogens 
and danger signals, orchestrating innate immune responses 
through activation of caspase-1, leading to the maturation 
of proinflammatory cytokines to produce IL-1β and IL-18. 
The inflammasome NLRP3 is the best characterized to date 
(Hoffman et al., 2001; Elliott and Sutterwala, 2015; Man and 
Kanneganti, 2015). It is composed of a pattern recognition 
receptor that belongs to the Nod-like receptor family (NLR), 
the adaptor protein apoptosis-associated speck-like protein 
with a CARD domain (ASC) and caspase-1. Its activation 
and assembly need two signals. The first signal, also known 
as priming, leads to transcription of genes encoding NLRP3 
and pro–IL-1β and occurs through activation of various re-
ceptors, such as TLRs (Bauernfeind et al., 2009). The second 
signal activates inflammasome assembly, resulting in the cata-
lytic processing of pro–caspase-1 into its enzymatically active 
form. NLRP3 inflammasome is activated by a wide range 
of stimuli, such as bacterial and viral pathogens, pore-form-
ing toxins, lipids, crystals, vaccine adjuvants, and stress cellu-
lar signals such as ATP.
Extracellular ATP is sensed by immune cells as a dan-
ger signal, and has been widely used as an inflammasome 
inducer. ATP exerts its biological action by binding to pu-
rinergic receptors such as P2X7 (P2X7R; Surprenant et al., 
1996; Mariathasan et al., 2006; Di Virgilio, 2015). P2X7R is a 
nonselective cationic channel abundantly expressed in mac-
rophages, whose activation promotes the opening of a pore 
that allows an influx of Na+ and Ca2+ into the cytosol and 
the concomitant efflux of K+ (Buisman et al., 1988). Thus, 
binding of ATP at high concentrations (millimolar range) 
to P2X7R promotes a decrease in intracellular K+ levels that 
triggers inflammasome assembly (Perregaux and Gabel, 1994; 
Mariathasan et al., 2006). However, in response to a pro-
longed exposure to agonists, P2X7R undergoes sensitization, 
resulting in increased current amplitudes and dilation of the 
pore, which can be permeable to large (≤800 D) inorganic 
and organic molecules (Surprenant et al., 1996; Di Virgilio, 
2015). Because the latter process could be damaging to the 
cell, the function of P2X7R needs to be tightly regulated, and 
finding cellular brakes for this receptor could be of special 
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interest both to restrain IL-1β production in inflammatory 
diseases, and also to stop undesired cell death.
Dysregulation of the NLRP3 inflammasome is asso-
ciated with a wide spectrum of autoinflammatoy diseases, 
characterized by recurrent fever and unprovoked episodes 
of inflammation, in which the monocyte-macrophage is the 
dysfunctional cell (Holzinger et al., 2015). Usually, blockade 
of IL-1β improves clinical symptoms in patients, whereas 
TNF neutralization, a highly effective therapy for autoim-
mune diseases, poorly controls autoinflammatory disorders 
(Quartier et al., 2011). From all autoinflammatory diseases 
characterized to date, it is interesting to highlight the Majeed 
syndrome, the molecular defect of which does not reside in 
mutations of genes related to inflammasome proteins or IL-1 
biology (Majeed et al., 1989). This syndrome is an autosomal 
recessive disease generated by mutations in the LPIN2 gene 
that encodes for lipin-2, a key enzyme in lipid metabolism 
(Ferguson et al., 2005; Al-Mosawi et al., 2007). Lipin-2 is a 
member of a family of proteins, the lipins, which catalyze 
the enzymatic conversion of phosphatidic acid to diacylglyc-
erol in a Mg2+-dependent manner (Péterfy et al., 2001). By 
regulating these two important cellular lipids, lipins can in-
fluence triacylglycerol and phospholipid biosynthetic path-
ways (Stein and Shapiro, 1957; Han et al., 2006; Kok et al., 
2012). Lipins have been found in macrophages, where lipin-1 
and lipin-2 seem to play opposite roles during inflammatory 
responses (Valdearcos et al., 2011, 2012; Meana et al., 2014; 
Navratil et al., 2015).
Five independent LPIN2 mutations are known to cause 
Majeed syndrome (Ferguson et al., 2005; Al-Mosawi et al., 
2007; Herlin et al., 2013; Rao et al., 2016). Four of these mu-
tations produce premature stop codons, and the last of them 
is a point mutation of a highly conserved residue among lip-
ins (Ser734), that eliminates lipin-2 PAP activity but not its 
ability to associate with microsomes (Donkor et al., 2009). 
Majeed syndrome may start very early in life (weeks) and 
its phenotype includes chronic recurrent multifocal osteomy-
elitis, congenital dyserythropoietic anemia, recurrent fevers 
and inflammation of the bone and skin (Majeed et al., 1989; 
Ferguson et al., 2005; Al-Mosawi et al., 2007). In Majeed 
syndrome patients, IL-1β blockade is accompanied by symp-
tomatic improvement on clinical and biological parameters 
(Herlin et al., 2013). These data strongly support the idea that 
IL-1β plays a key role in the development of the disease. The 
underlying mechanisms by which mutations in LPIN2 cause 
this syndrome are unknown. Because of the involvement of 
IL-1β in this process, we hypothesized that lipin-2 might be 
involved in its production and, therefore, in the regulation of 
inflammasome activity. Accordingly, in the present study we 
have examined the role of lipin-2 in inflammasome activa-
tion and IL-1β production in primary BM-derived macro-
phages (BMDMs) from Lpin2−/− mice and primary human 
macrophages made deficient in lipin-2. We found that lipin-2 
controls both the priming and activation phase of the inflam-
masome NLRP3. Specifically, lipin-2 limits TLR4 activation 
and maintains a proper lipid environment for P2X7R that 
inhibits its overactivation. These results expand the role of 
lipin-2 as an important innate immune regulator.
resuLts
Lipin-2 restrains IL-1β production by nLrP3 inflammasome
Patients with mutations in the LPIN2 gene have increased 
levels of IL-1β in serum (Herlin et al., 2013). However, it is 
not known whether mutated lipin-2 has a direct effect on 
IL-1β–producing cells. To answer this question, lipin-2 ex-
pression was knocked-down by siRNA technology in human 
macrophages. IL-1β production was triggered by classical ac-
tivation of NLRP3 inflammasome, i.e., LPS as the priming 
signal and ATP as the second signal. We found that decreased 
cellular levels of lipin-2 resulted in a significant increase in 
the production of IL-1β in these cells (Fig.  1  A). To fur-
ther characterize this finding, we evaluated the production 
of the cytokine in BMDMs from Lpin2−/− mice, where the 
absence of the enzyme is complete. Again, these cells had a 
larger capacity for producing IL-1β than BMDMs generated 
from WT animals (Fig. 1, B and D). Furthermore, elimina-
tion of the enzyme in the murine cell line RAW264.7 also 
promoted increased IL-1β production with respect to control 
cells (Fig.  1 C). We then investigated whether NLRP3 in-
flammasome contributed to those observed effects. Fig. 1 E 
shows that absence of key elements of the NLRP3 inflam-
masome, such as the NLRP3 sensor, the ASC adapter, or the 
effector protein caspase-1 in BMDM cells, completely ab-
rogated the cell’s capacity to generate IL-1β, either in the 
presence or absence of lipin-2. These data suggest that the 
overstimulating effect of lipin-2 on IL-1β production works 
through the NLRP3 inflammasome.
Lipin-2 ameliorates tLr4 signaling
To evaluate whether lipin-2 is implicated in TLR4 activa-
tion, we analyzed first mRNA levels for Tnf, a gene classically 
up-regulated by LPS. We found that the mRNA levels for 
this gene, as well as the levels of secreted TNF were higher 
in BMDMs from Lpin2−/− animals than in WT cells (Fig. 2, 
A and B). By analyzing Il1b mRNA and pro–IL-1β we also 
observed the same behavior (Fig. 2, C and D). Importantly, 
human macrophages made deficient in lipin-2 also pro-
duced higher levels of TNF and had higher levels of IL1B 
mRNA (Fig. 2, B and C).
We then studied whether, during LPS treatment, 
MAPKs phosphorylation was also affected by lipin-2. The 
results demonstrated that BMDMs from Lpin2−/− animals 
had increased phosphorylation levels for ERK, JNK, and 
p38, especially after 30 min of stimulation (Fig. 2 E). Next, 
the impact of these kinases on Il1b mRNA production was 
evaluated by using specific inhibitors. Inhibition of p38 
(SB203580) completely abolished Il1b mRNA up-regulation 
independently of the level of lipin-2, whereas JNK inhibi-
tion (SP600125) completely blocked the overproduction of 
the cytokine generated by lipin-2–deficient cells. Similarly, 
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ERK inhibition (PD98059) had a modest but significant ef-
fect on Il1b mRNA generated in BMDMs from Lpin2−/− 
animals, but not in WT animals (Fig. 2 F). As expected from 
the mRNA expression data, when cells were treated with p38 
inhibitor before the priming step, IL-1β release was strongly 
inhibited in both cellular phenotypes, abrogating the over-
production observed in lipin-2–deficient cells. ERK and JNK 
inhibitors reduced the overproduction generated in BMDMs 
from Lpin2−/− animals under these conditions (Fig. 2 G).
Phosphorylation events occurring after TLR4 activa-
tion may also impact NLPR3 inflammasome proteins, fa-
voring the second step of inflammasome activation (Hara et 
al., 2013). We performed experiments where inhibitors were 
added between the priming and the inflammasome activa-
tion step to ensure that the pro–IL-1β was not perturbed 
(Fig. 2 G). Using this strategy, we found that ERK and p38 
inhibition affected IL-1β maturation in lipin-2–deficient 
cells, decreasing cytokine production to levels found in WT 
cells, whereas JNK inhibition reduced IL-1β maturation in 
both WT and lipin-2–deficient cells.
We also observed that Nlrp3 mRNA and NLPR3 pro-
tein levels were increased in BMDMs from Lpin2−/− animals 
(Fig. 2, H and I). Collectively, these results show that signaling 
during inflammasome priming by LPS is reduced by lipin-2.
Lipin-2 controls caspase-1 activation
To investigate the role of lipin-2 in inflammasome activa-
tion, we took advantage of the fact that pro–IL-18 is also 
Figure 1. the effect of lipin-2 on IL-1β production by murine and human macrophages. IL-1β presence in supernatants from primary human 
macrophages (A), BMDMs from WT and Lpin2−/− mice (B and D), or RAW264.7 cells (C) stimulated with 200 ng/ml LPS for 4 h, 2 mM ATP for 40 min, or 
both, as indicated, were quantified by specific ELI SAs. (A–C) Human macrophages and RAW264.7 cells were silenced as described in Materials and methods, 
using control (siRNACtrl.) and lipin-2–specific siRNAs (siRNALpin2). (right) Lpin2 mRNA levels at the time of stimulation. (D) BMDMs supernatants were 
analyzed by immunoblot using specific antibodies against IL-1β. (right) Densitometric quantification of the bands. (E) IL-1β production was analyzed in 
BMDMs supernatants from WT, Nlrp3−/−, Asc−/−, and Casp1−/− animals treated with a control siRNA (siRNACtrl.) or siRNAs against Lpin2 (siRNALpin2) for 
2 d, and then stimulated as indicated. (right) Level of Lpin2 mRNA after silencing. Data from A–C and E are shown as means ± SD and are representative 
of at least three independent experiments made in triplicate. Data from D are representative of at least three independent experiments. *, P < 0.05; **, P < 
0.01; ***, P < 0.001, Student’s t test.
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Figure 2. the effect of lipin-2 on tLr4 signaling. (A) WT and Lpin2−/− BMDMs were stimulated with 200 ng/ml LPS for the indicated periods of time, 
and then mRNA levels for Tnf were quantified by RT-qPCR. (B) Quantification of TNF present in cellular supernatants from WT and Lpin2−/− BMDMs (left) 
or silenced human macrophages (right) treated with 200 ng/ml LPS for 4 h. (C) Quantification of Il1b mRNA levels from WT and Lpin2−/− BMDMs (left), or 
silenced human macrophages (right) stimulated with LPS. (D) Analysis by Immunoblot of pro–IL-1β present in homogenates from BMDMs (left). (right) 
Relative expression levels of IL-1β against β-actin. (E) Analysis by immunoblot of MAPKs and their phosphorylated forms present in BMDMs activated as 
in A (left). (right) Relative quantification of phosphoproteins against total proteins. (F) Control (siRNACtrl.) and lipin-2–silenced (siRNALpin2) RAW264.7 
cells were pretreated with 10 µM PD98059, SP600125, or SB203580 for 30 min, and then stimulated with 200 ng/ml LPS for 4 h. Il1b mRNA levels were 
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processed by activated caspase-1, but its expression is con-
stitutive in cells (Gu et al., 1997). Our results showed that 
there was an increased production of IL-18 in Lpin2−/− 
BMDMs and lipin-2–deficient human macrophages com-
pared with control cells, whereas the levels of mRNA for 
Il18/IL18 did not change (Fig. 3, A and B). Of note, just 
ATP, without priming, was sufficient to produce mature IL-
18, and the absence of lipin-2 further increased this pro-
duction, indicating an overactivation of the inflammasome 
under these circumstances. We also found that BMDMs 
from Lpin2−/− animals had an increased release of mature 
caspase-1 after inflammasome activation compared with 
control cells (Fig. 3 C). Analysis of intracellular caspase-1 ac-
tivity demonstrated that cells with reduced levels of lipin-2 
were more prone to activate caspase-1 (Fig. 3 D). To further 
demonstrate that caspase-1 is responsible for IL-1β process-
ing, the general inhibitor of caspases ZVAD as well as the 
specific inhibitor for caspase-1, YVAD, were used. Both of 
them effectively blocked the generation of IL-1β without 
affecting TNF generation in BMDMs from Lpin2−/− and 
WT animals, as well as in human macrophages (Fig. 3, E and 
F). As a consequence of caspase-1 activation, macrophages 
deficient in lipin-2 had increased pyroptosis levels after LPS 
plus ATP treatment, as shown by lactate dehydrogenase 
(LDH) release (Fig. 3 G). Analysis of propidium iodide (PI) 
incorporation confirmed that lipin-2–deficient cells were 
more permeable than WT cells after inflammasome activa-
tion (Fig. 3 H). Altogether, these experiments demonstrate 
that lipin-2 controls caspase-1 activation during classical 
inflammasome activation.
Lipin-2 inhibits inflammasome assembly
Oligomerization of ASC promoted by activation of the 
NLRP3 inflammasome is an upstream event that is responsi-
ble for recruitment and activation of caspase-1. We analyzed 
whether oligomerization of ASC was affected by lipin-2. 
Analysis of ASC oligomers performed by disuccinimidyl 
suberate cross-linking showed that BMDMs from Lpin2−/− 
mice had increased ASC oligomerization compared to con-
trol cells after inflammasome activation (Fig.  4  A). Also, 
examination of BMDMs by confocal microscopy showed 
an increased number of ASC specks (inflammasomes) and 
a tendency to produce bigger specks in cells from Lpin2−/− 
mice than cells from WT animals (Fig. 4, B–D). These results 
indicate that lipin-2 decreases ASC oligomerization and 
inflammasome assembly.
Lipin-2 regulates P2X7r pore formation
In the next series of experiments, we analyzed whether lipin-2 
exerted any influence on the production of IL-1β by other 
NLRP3 activators in addition to ATP. Inflammasome was ac-
tivated by nigericin, monosodium urate, and alum in primed 
macrophages (Fig. 5 A). Although there was a tendency for 
cells expressing low levels of lipin-2 to produce more IL-1β 
than control cells with the aforementioned NLRP3 activa-
tors, there was no significant difference. These results suggest 
that, of the NLRP3 activators tested, only the response to 
ATP was regulated by lipin-2. This finding led us to examine 
whether lipin-2 regulates the activity of P2X7R. Whole-cell 
patch clamp experiments shown in Fig. 5 demonstrated that 
acute extracellular application of ATP activates inward (–120 
mV) and outward (+100 mV) currents through the P2X7R, 
whose amplitude is dramatically enhance in macrophages 
from Lpin2−/− mice compared with control cells. The rever-
sion potential of the cells in those conditions was close to 0 
mV, independent of lipin-2 expression levels (Fig. 5 B). When 
sodium in the standard extracellular solution was substituted 
by N-methyl-d-glucamine, an organic large monovalent cat-
ion, WT cells showed a significant reduction in inward cur-
rents after ATP treatment, with a reversion potential close to 
–50 mV. However, cells from Lpin2−/− mice underwent in-
creased outward currents after ATP treatment. The reversion 
potential for these cells was –30 mV, i.e., very different from 
the membrane potential in resting conditions, which is close 
to –80 mV. By analyzing the mean current densities, we found 
that cells with reduced expression of lipin-2 have increased 
inward and outward currents during ATP stimulation (Fig. 5, 
C and D). These data suggest that ATP promotes the P2X7R 
opening to a dilated state that is larger when lipin-2 is absent.
The temporal course of P2X7R pore opening and clo-
sure was also studied. The data showed that although there 
was not a for the opening velocity of the pore (ton) between 
cells with different levels of lipin-2, the P2X7R pore from 
Lpin2−/− cells experienced a delayed closure (higher toff) 
compared with control cells (Fig.  5  E). Collectively, these 
results suggest that lipin-2 controls the amplitude of the 
P2X7R pore formed after challenging with ATP, and also 
the time the pore is open.
Lipin-2 controls intracellular K+ levels and membrane 
permeability during P2X7r activation
 Because the fall of intracellular K+ levels is a mechanism 
for NLRP3 activation (Muñoz-Planillo et al., 2013) we 
quantified by RT-qPCR. (G) WT and Lpin2−/− BMDMs were treated with inhibitors before or after stimulation with LPS. Stimulations were as indicated. 
IL-1β present in cellular supernatants is shown. (H) WT and Lpin2−/− BMDMs were stimulated with LPS as in A, and then Nlrp3 mRNA levels were quantified. 
(I) Analysis by immunoblot of NLRP3 present in cellular homogenates from BMDMs stimulated as in A (left). (right) Relative NLRP3 expression levels against 
β actin. β-Actin bands are the same as shown in E because the same blot was used. Data from A–C and F–H are shown as mean ± SD, and experiments 
shown are representative of at least three independent experiments made in triplicate. Data from D, E, and I are representative of at least three independent 
experiments. *, P < 0.05; **, P < 0.01; ***, P < 0.001, Student’s t test. #, P < 0.05; ###, P < 0.001, versus siRNALpin2 + LPS cells (F), or Lpin2−/− + LPS/ATP cells 
(G) by Student’s t test.
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studied whether lipin-2 influences intracellular K+ levels in 
ATP-stimulated cells. The results showed that K+ levels fell 
sharply after ATP treatment, nearing 10% of initial intracel-
lular K+ concentration in only 2 min (Fig. 6 A). Significant 
differences between WT and lipin-2–deficient cells were 
already found at this short time. After 4 min of treatment, 
intracellular K+ concentrations started to recover, reaching a 
plateau at ∼15 min, with values of 27% for WT cells and 
18% for lipin-2–deficient cells (Fig. 6 A). Thus, cells lacking 
lipin-2 maintained lower K+ levels after ATP treatment than 
Figure 3. the effect of lipin-2 on 
caspase-1 activation. (A) WT and Lpin2−/− 
BMDMs (left) or silenced human macrophages 
(right) were stimulated with 200 ng/ml LPS for 
4 h or the indicated periods of time, 2 mM ATP 
for 40 min, or both, as indicated. IL-18 present 
in cellular supernatants was quantified by spe-
cific ELI SAs. (B) Cells as in A were stimulated 
with LPS and Il18 mRNA levels were quanti-
fied by RT-qPCR. (C) Analysis by immunoblot 
of active caspase-1 present in supernatants 
from WT and Lpin2−/− BMDMs (top). (bottom) 
Densitometric quantification of the bands. (D) 
Analysis of intracellular active caspase by flow 
cytometry in RAW264.7 cells treated with con-
trol siRNA (siRNACtrl.) or siRNA against lipin-2 
(siRNALpin2) and stimulated as in A. Median 
fluorescence intensities (MFI) are indicated 
(left). (right) Percentage of cells with active 
caspase-1. (E and F) WT and Lpin2−/− BMDMs 
(E) or silenced human macrophages (F) were 
pretreated with 10 µM YVAD or ZVAD for 30 
min and then stimulated as in A. (G) IL-1β (left) 
and TNF (right) present in cellular supernatants 
were quantified by specific ELI SAs. LDH release 
from RAW264.7 cells treated as in D. (H) Analy-
sis by flow cytometry of RAW264.7 cells treated 
as in D and stained with propidium iodide (PI; 
left). (right) Percentage of cells positive for PI. 
Data from A, B, and E–G are shown as mean 
± SD, and experiments shown are representa-
tive of at least three independent experiments 
made in triplicate. Data from C, D, and H are 
representative of at least three independent 
experiments. *, P < 0.05; **, P < 0.01; ***, P < 
0.001, Student’s t test. (E) ###, P < 0.001, versus 
Lpin2−/− + LPS/ATP cells by Student’s t test.
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WT cells. These results are fully consistent with the patch 
clamp experiments showing that P2X7R pore is larger and 
stays open for longer period of time in the absence of lipin-2, 
allowing a prolonged exit of K+.
Experiments were then performed where extracellular 
K+ concentrations were manipulated. At 45 mM extracellular 
K+ (where the intracellular K+ drop is prevented), the pro-
duction of IL-1β was inhibited compared with 5 mM K+ (the 
physiological extracellular concentration) in both lipin-2– 
deficient and control cells, and no significant differences could 
be found between them (Fig. 6 B). However, in the absence 
of extracellular K+, which favors cellular exit of the cation, 
the production of IL-1β was higher in both WT and lipin-2–
deficient cells than at physiological K+ levels, but cells lack-
ing lipin-2 were still able to produce more IL-1β than WT 
cells (Fig. 6 B). These experiments suggest again a key role 
for K+ in the overactivation of the NLRP3 inflammasome in 
the absence of lipin-2.
Examination of P2X7R pore formation by analyzing the 
uptake of ethidium bromide in living cells by confocal mi-
croscopy showed that cells lacking lipin-2 displayed a higher 
and faster ethidium bromide uptake than WT cells (Fig. 6 C).
Increased membrane permeability generated by P2X7R 
activation at later stages can also be evaluated by the en-
trance of small proteins such as Annexin V, which binds to 
the phosphatidylserine molecules present in the internal 
leaflet of the cell membrane (Brennan and Cookson, 2000). 
Analysis of permeability to Annexin V showed that cells with 
reduced levels of lipin-2 displayed increased Annexin V bind-
ing to membranes, which was very evident after 50 min of 
ATP treatment (Fig. 6 D).
Altogether, these results indicate that lipin-2 reduces 
ATP-promoted K+ efflux that is responsible for IL-1β pro-
duction, as well as P2X7R pore formation, during classical 
inflammasome activation.
Lipin-2–deficient macrophages display low cholesterol 
levels that affect P2X7r activation
As a result of the role of lipin-2 in lipid metabolism, the as-
sumption could be made that the effects of the enzyme on 
P2X7R would be related to changes in the composition or 
concentration of certain lipids. In this regard, cholesterol 
levels have been found to negatively regulate P2X7R activa-
tion (Michel and Fonfria, 2007; Robinson et al., 2014). We 
then analyzed cellular cholesterol levels in BMDMs from 
Lpin2−/− mice, and found that there was a significant reduc-
tion in its levels compared with WT cells (Fig. 7 A), especially 
in basal conditions and after stimulation with LPS. Differ-
ences in cholesterol levels were also found in lipin-2–silenced 
RAW264.7 cells under all conditions studied (Fig. 7 A). Ex-
periments were conducted to reestablish cholesterol levels in 
cells deficient in lipin-2, and this was achieved by incubating 
Figure 4. the effect of lipin-2 on Asc oligo-
merization and inflammasome assembly. BMDMs 
from WT and Lpin2−/− mice (A–D) were treated with 
200 ng/ml LPS for 4 h, 2 mM ATP for 40 min, or both, 
as indicated. (A) Proteins from whole-cell lysates and 
purified cross-linked ASC oligomers were analyzed 
by immunoblot using specific antibodies against ASC 
or β-actin as a loading control. (B and C) Cells were 
stimulated as indicated and stained with specific an-
tibodies against ASC and DAPI, as mentioned in the 
Materials and methods. Fluorescence was imaged by 
confocal microscopy. Bars: (B) 10 µm; (C) 50 µm. Ar-
rowheads denote ASC specks. (D) Fold increase in ASC 
speck production from 700–1,400 cells is shown. Data 
from A–D are representative of at least three indepen-
dent experiments. Data from D are shown as means ± 
SD *, P < 0.05, Student’s t test.
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the cells with 100 µg/ml cholesterol loaded in methyl-β- 
cyclodextrin (MCD), to make it water soluble (Robinson et 
al., 2014). This treatment completely restored cholesterol levels 
in lipin-2–deficient cells (Fig. 7 B). These conditions were then 
used to study whole-cell currents mediated by the P2X7R. We 
observed that pretreatment of cells with cholesterol profoundly 
reduced inward and outward currents generated by ATP treat-
ment in macrophages from Lpin2−/− mice, producing no signif-
icant changes in WT cells (Fig. 7 C). Accordingly, mean current 
density analyses revealed that elevated inward and outward cur-
rents generated in lipin-2–deficient cells were reduced in those 
cells when cholesterol levels were restored, the effect being es-
pecially observable for outward currents (Fig. 7 D). Analyses 
of the temporal behavior of P2X7R showed that cholesterol 
treatment reduced the time needed for P2X7R to close (toff) 
in macrophages from Lpin2−/− mice and again, the effect was 
especially relevant for the outward currents (Fig. 7 E). There 
were no effects of cholesterol on toff for WT cells under these 
conditions. Overall these results are consistent with lipin-2 
controlling the levels of cholesterol in macrophages, which 
in turn regulates P2X7R behavior, reducing current density 
through the channel by decreasing the opening of the pore and 
accelerating its rate of closure.
cholesterol treatment reverses inflammasome 
overactivation in lipin-2–deficient cells
To assess whether restoration of cholesterol levels could af-
fect the overactivation of the inflammasome in cells defi-
cient in lipin-2, we evaluated P2X7R downstream events 
during inflammasome activation, i.e., ASC speck assem-
bling, caspase-1 activation, and IL-1β production. For these 
experiments, cholesterol treatment was always performed 
30 min before ATP treatment to evaluate only the effects 
on the second signal of inflammasome activation. Under 
these conditions, cholesterol loading reduced ASC oligo-
mers present in BMDMs from Lpin2−/− mice to levels pres-
ent in WT cells after inflammasome activation (Fig.  8  A). 
Figure 5. the effect of Lipin-2 on cellular ionic currents generated 
by AtP. RAW264.7 cells treated with control siRNA (siRNACtrl.), siRNA 
against lipin-2 (siRNALpin2; A, left), or BMDMs from WT and Lpin2−/− mice 
(A, right) were stimulated with 100 ng/ml LPS for 4 h, 2 mM ATP or 10 µM 
nigericin for 40 min, 200 µg/ml monosodium urate (MSU) or 150 µg/ml 
alum for 6 h, or LPS for 4 h, followed by ATP or nigericin for 40 min, MSU, 
or alum for 6 h, as indicated. IL-1β present in cellular supernatants was 
analyzed by specific ELI SA (A). (B) Representative traces obtained with 
whole-cell recordings using a 1-s ramp protocol in peritoneal macro-
phages from WT and Lpin2−/− animals stimulated with 2 mM ATP in control 
solution (140 mM NaCl) or in a solution where NaCl has been substituted 
for 140  mM N-methyl-d-glucamine (NMDG), as indicated. (top) Current 
density versus voltage plots; (bottom) time course of the current density 
at −120 and +100 mV. (C) Mean current density from 25–39 macrophages 
analyzed is shown. RAW264.7 cells were also evaluated as in B and mean 
current density from 18 cells is shown (D). Time course of the current am-
plitude obtained at −120 mV and +100 mV in a peritoneal macrophage 
from WT mice upon exposure to 2 mM ATP during the indicated time, to il-
lustrate the calculations of ton (time from opening to maximal stimulation) 
and toff (time from maximal opening to closure; E, left). (right) Mean ton 
and toff for −120 mV and +100 mV from WT and Lpin2−/− mice peritoneal 
macrophages (14–40 cells) stimulated with 2 mM ATP (E). Data from A are 
shown as mean ± SD, and experiments shown are representative of at least 
three independent ones made in triplicate. *, P < 0.05, Student’s t test. Dada 
from C, D, and E, are shown as means ± SEM *, P < 0.05; **, P < 0.01; ***, P 
< 0.001, one-way ANO VA, followed by Tukey's test.
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When caspase-1 activation was analyzed by flow cytom-
etry, it was also found that cholesterol treatment reduced 
both the amount of active caspase-1 per cell (MIF) and the 
percentage of cells that have active caspase-1 in lipin-2–
deficient cells, with no significant changes in control cells 
(Fig.  8 B). Finally, IL-1β production was reduced by cho-
lesterol treatment in cells deficient in lipin-2 without sig-
nificant changes in control cells (Fig.  8  C). Collectively, 
these results demonstrate that restoration of cholesterol 
levels during the second signal of inflammasome activation 
reduces inflammasome assembly, caspase-1 activation, and 
IL-1β production in cells deficient in lipin-2.
Lipin-2 restrains inflammasome activation in vivo in mice
To assess whether the observed effects of lipin-2 on inflam-
masome activation in vitro could be translated to in vivo an-
imal models of inflammasome activation, we evaluated IL-1β 
production in animals after 3 h of intraperitoneal injection of 
10 mg/kg LPS. Consistent with our previous results, Lpin2−/− 
mice had exacerbated responses to LPS, producing higher 
amounts of IL-1β (Fig. 9 A). In addition, we also observed 
enhanced production of IL-18 (confirming inflammasome 
activation) and TNF (confirming TLR4 enhanced activation), 
although in the latter case differences were less pronounced 
(Fig. 9 A). Analysis of tissues that undergo a strong inflamma-
Figure 6. effect of lipin-2 on AtP-induced changes in K+ cellular levels and cell permeability. (A) Control (siRNACtrl.) and lipin-2–silenced 
(siRNALpin2) RAW264.7 cells were stimulated with 2 mM ATP for the indicated periods of time, and intracellular concentration of K+ was analyzed using 
an inductively coupled plasma/optical emission spectrometer. (B) RAW264.7 cells were stimulated with 200 ng/ml LPS for 4 h, and then 2 mM ATP for 40 
min, as indicated, in the presence of 0, 5, or 45 mM K+. IL-1β present in cellular supernatants was analyzed by specific ELI SAS. (C) BMDMs from WT and 
Lpin2−/− mice were pretreated with 20 µM ethidium bromide (BrEt) for 5 min, and then stimulated with 2 mM ATP. Ethidium cellular uptake was monitored 
by confocal microscopy. (top) Cell fluorescence; (bottom) fluorescence fold increase over time. Bar, 25 µm. (D) Control (siRNACtrl.) and lipin-2–silenced 
(siRNALpin2) RAW264.7 cells were stimulated with 2 mM ATP for 50 min in the presence of Annexin-V-Cy3, and fluorescence analyzed in a confocal micro-
scope (top). (bottom) Fluorescence fold increase over unstimulated cells. Bar, 50 µm. Data from A and B are shown as mean ± SD, and experiments shown 
are representative of at least three independent experiments made in triplicates. Data from C (>100 cells) and D (>300 cells) are shown as means ± SEM, 
and experiments shown are representative of at least three independent ones. *, P < 0.05; **, P < 0.01; ***, P < 0.001, by Student’s t test.
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Figure 7. Impact of lipin-2 on cellular cholesterol levels, and restoration of P2X7r functionality by cholesterol in the absence of lipin-2. 
(A) BMDMs from WT and Lpin2−/− mice (left), or control (siRNACtrl.) and lipin-2–silenced (siRNALpin2) RAW264.7 cells (right) were treated with 200 ng/ml 
LPS for 4 h, 2 mM ATP for 40 min, or both, as indicated. (B) Total cellular cholesterol levels were analyzed as described in Materials and methods. RAW264.7 
cells preincubated with 100 µg/ml cholesterol (cholesterol/MCD) for 30 min were treated as in A, and total cellular cholesterol levels were measured. 
(C) Example traces of whole-cell ionic currents analyzed by patch-clamp in peritoneal macrophages from WT and Lpin2−/− animals stimulated with 2 mM 
ATP in the absence or presence of 100 µg/ml cholesterol (cholesterol/MCD) as indicated. (top) Current density against voltage; (bottom) current densities 
at −120 and +100 mV. (D) Mean current density from 15–18 cells analyzed. (E) The mean ton and toff at −120 and +100 mV from WT and Lpin2−/− mice 
peritoneal macrophages stimulated with 2 mM ATP in the presence or absence of 100 µg/ml cholesterol (cholesterol/MCD). Data from A and B are shown as 
mean ± SD, and experiments shown are representative of at least three independent experiments made in triplicate. Data from D and E are shown as means 
± SEM *, P < 0.05; **, P < 0.01; ***, P < 0.001, Student’s t test (A and B) or by one-way ANO VA followed by Tukey's test (D and E).
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tory response during LPS treatment demonstrated that the 
liver of animals deficient in lipin-2 have stronger responses 
to treatment with the endotoxin, producing higher levels of 
mRNA for Il1b, Il6, Tnf, Il12b, Nos2, and Il1r (Fig. 9 B). In 
parallel, there was a higher production of Il1b and Tnf in the 
spleen (Fig. 9 C). It should also be noted that mRNA expres-
sion of antiinflammatory cytokines like Il10 was significantly 
reduced in spleens of Lpin2−/− mice (Fig. 9 C). There were 
increased Nlrp3 mRNA levels in livers and spleens of animals 
deficient in lipin-2 after LPS treatment. Collectively, these 
results confirm the inhibitory role of lipin-2 during inflam-
masome activation in vivo.
dIscussIon
Inflammasome activation is a complex process where many 
different pathways converge, but the contribution of lipid- 
related enzymes has been scarcely investigated to date. Here, 
we describe that lipin-2, a phosphatidic acid phosphohydro-
lase, plays a significant regulatory role, by modulating the 
extent of inflammasome activation via different mechanisms 
(Fig. 9 D). In the first place, lipin-2 reduces MAPKs activa-
tion during the priming phase, thus diminishing the levels of 
pro–IL-1β. Second, lipin-2 facilitates an appropriate lipid en-
vironment for P2X7R, which regulates the amplitude of the 
pore formed after activation and the open to close transitions. 
As a consequence of this, ion currents are lower, especially 
K+ currents, which negatively impact on NLRP3 inflam-
masome activation, ASC oligomerization, pro–caspase-1 pro-
cessing and IL-1β and IL-18 maturation. These findings are 
of pathophysiologically relevance, as mutations in the LPIN2 
gene produce an autoinflammatory condition, and provide a 
mechanism by which a lipid-related enzyme controls inflam-
masome activation in murine and human macrophages. Thus, 
the results may help formulate new avenues for the treat-
ment of patients with Majeed syndrome, whose symptoms 
are treated at this moment with expensive biological therapies 
using antibodies against IL-1β or recombinant IL-1 receptor 
antagonists (Herlin et al., 2013).
Figure 8. cholesterol effect on Asc oligomerization, capase-1 activation, and IL-1β production in the absence of lipin-2. (A) BMDMs from WT 
and Lpin2−/− mice were treated with 200 ng/ml LPS for 4 h, 2 mM ATP, or both, as indicated. Some samples were preincubated with 100 µg/ml cholesterol 
30 min before ATP treatment, as indicated. Proteins from whole-cell lysates and purified cross-linked ASC oligomers were analyzed by immunoblot using 
specific antibodies against ASC or β-actin, as a loading control. (B) Control (siRNACtrl.) or lipin-2–silenced (siRNALpin2) RAW264.7 cells were treated with 
200 ng/ml LPS for 4 h and then 2 mM ATP for 40 min, as indicated. Some samples were preincubated with 100 µg/ml cholesterol (cholesterol/MCD) 30 min 
before ATP treatment, as indicated. Intracellular active caspase was analyzed by flow cytometry as specified in Materials and methods. Median fluorescence 
intensities (MFI) are indicated. (bottom) Percentage of cells with active caspase-1. (C) RAW264.7 cells were treated as in B and presence of IL-1β in cellular 
supernatants was quantified by specific ELI SA in triplicate samples. Data are shown as means ± SD, and experiments shown are representative of at least 
three independent experiments. *, P < 0.05; **, P < 0.01, by Student’s t test.
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Lipin-2 restricts overphosphorylation of ERK, p38, 
and JNK, with different consequences for IL-1β synthesis. 
The effect of p38 on Il1b mRNA levels was previously de-
scribed in cell lines (Baldassare et al., 1999), and our cur-
rent results confirm this to happen in primary cells as well. 
We have found that the control that lipin-2 exerts over p38 
is also key during IL-1β maturation. Overall, p38 inhibition 
results in >85% reduction in IL1-β production, which pro-
vides a very interesting possibility to consider as an alternative 
strategy for the treatment of patients with Majeed syndrome. 
Figure 9. the effect of lipin-2 in the response to LPs 
in mice. (A) WT and Lpin2−/− mice (n = 5) were intraperi-
toneally injected with 10 mg/kg of LPS or PBS. 3 h later, in-
dicated cytokines were quantified in serum using specific 
ELI SA. Expression levels of the indicated genes were ana-
lyzed in liver (B) or spleen (C) by RT-qPCR. (D) Proposed 
scheme depicting lipin-2 effects on priming and activa-
tion of the inflammasome. Data are shown as means ± SD, 
and experiments shown are representative of at least two 
independent ones analyzed in triplicates. *, P < 0.05; **, P 
< 0.01; ***, P < 0.001, by Student’s t test.
 o
n
 D
ecem
ber 13, 2017
jem.rupress.org
D
ow
nloaded from
 
523JEM Vol. 214, No. 2
However, p38 might still be a very upstream target in the 
signaling cascade that culminates in the generation of Il1b 
mRNA, in which case it would be important to elucidate 
the downstream transcription factors that are affected by the 
kinase, especially in the absence of lipin-2. In this regard, C/
EBPβ has been shown to be responsible of IL-1β up-reg-
ulation (Baldassare et al., 1999; Basak et al., 2005). On the 
other hand, ERK and JNK seem to specifically control IL-1β 
maturation in cells lacking lipin-2, although ERK may also 
affect mRNA levels for the cytokine in those circumstances. 
In this context, a key role has been described for JNK that, 
by phosphorylating ASC in Tyr144, promotes ASC specks 
assembling and caspase-1 activation (Hara et al., 2013). No 
evidence exists to date that ERK could also have a role on 
inflammasome assembly/activation.
A recent work on mutational analysis of P2x7R suggests 
the involvement of multiple cholesterol recognition amino 
acid consensus motifs in the N and proximal C-terminal 
region of the receptor that could be related to the choles-
terol sensitivity of channel gating (Robinson et al., 2014). 
However, it is also possible that reduced cholesterol levels in-
creases membrane fluidity and/or arrangement of other lipids 
around the receptor, promoting a state of pore dilation. The 
fact that cholesterol levels are altered by lipin-2 and that the 
P2X7R functionality is also modified by lipin-2 lead us to 
speculate about the possible involvement of this lipid in the 
regulation that the enzyme exerts on P2X7R responses. In 
this regard, our results raise intriguing questions as to how 
lipin-2 may regulate cholesterol levels in cells. Other lipins, 
such as lipin-1, have previously been described to regulate 
SRE BP nuclear protein abundance and up-regulation of 
cholesterol and lipid biosynthetic enzymes (Peterson et al., 
2011). The effect takes place by inhibiting mTORC1 activ-
ity and dephosphorylation of lipin-1, but the mechanism by 
which lipin-1 directly inhibits SRE BP nuclear presence has 
not yet been elucidated (Peterson et al., 2011). It is possible 
that lipin-2 may also regulate SRE BP activity/localization or 
any other important step that determines cellular cholesterol 
homeostasis: influx, synthesis, esterification, or efflux. Ongo-
ing work in our laboratory using lipin-2–overexpressing cells 
(Valdearcos et al., 2012) suggests that cellular levels of choles-
terol are elevated, and we are trying to define which of the 
aforementioned events are affected.
In addition to NLRP3, the possibility exists that other 
IL-1β–producing inflammasomes may also be affected by 
lipin-2 deficiency. Our preliminary observations suggest that 
the NLRC4 could be one of these (unpublished data). Re-
cently, the pyrin inflammasome has been found to be acti-
vated after inactivation of RhoA GTPases by bacterial toxins 
(Xu et al., 2014; Park et al., 2016). RhoA needs to be gera-
nylgeranylated for membrane targeting and full activity (Hori 
et al., 1991). Geranylgeranyl pyrophosphate, a metabolite of 
the intermediate of the cholesterol synthesis pathway farnesyl 
pyrophosphate, is the substrate for protein geranylgeranyla-
tion (Lutz et al., 1992). Because the results of our study show 
that lipin-2–deficient cells exhibit decreased cholesterol con-
tent, it is tempting to speculate that the production of ger-
anylgeranyl pyrophosphate could be decreased as well, this 
leading to deficient RhoA geranylgeranylation and activation. 
In such scenario, the pyrin inflammasome activation would 
be enhanced. Studies are currently in progress to examine 
this attractive hypothesis.
The increased sensitivity of Lpin2−/− mice to inflamma-
tion induced by LPS emphasizes the role of lipin-2 as a crit-
ical regulator of inflammation in vivo, and recapitulates the 
findings in vitro. Because significant effects on inflammasome 
activation and systemic inflammation were already observed 
at 3 h LPS, we did not conduct measurements at longer times. 
We do not rule out that, with longer times of LPS exposure, 
bone inflammation and damage may develop, as reported by 
others (Sakuma et al., 2000; Ochi et al., 2010). In these mod-
els, significant bone damage takes 2–10 d of LPS treatment 
to occur. The process is slow, likely because new osteoclasts 
need to differentiate from their precursors in the bone mar-
row (Udagawa et al., 1990). Similar to previous observations, 
we have not found any particular autoinflammatory pheno-
type in otherwise untreated animals (Dwyer et al., 2012). This 
behavior further strengthens the hypothesis that the way an-
imals are stocked may preclude their exposure to ambient 
contaminants or microorganisms that could possibly trigger 
those symptoms (Dwyer et al., 2012). Nevertheless, based on 
our results, the differences between patients and mutant mice 
could also be related to differences in the human versus the 
mice P2X7Rs. The human receptor seems to be much more 
sensitive to cholesterol level changes than the murine recep-
tor (Robinson et al., 2014), which suggests that in humans 
small modifications in the concentration of cholesterol could 
exacerbate P2X7R function and inflammasome activation 
when the proper circumstances are present.
Studies in humans and murine models have revealed 
that P2X7R is involved in many immunoinflammatory, neu-
rological, and musculoskeletal disorders (Bartlett et al., 2014). 
Because diminished lipin-2 levels appears to increase P2X7R 
activity, the possibility exists that Majeed syndrome patients 
would be more susceptible to the development of other dis-
orders different from autoinflammation, which are related to 
dysregulated P2X7R activity.
Overall our studies reveal the importance of lipin-2 in 
the control of TLR4 signaling, and P2X7R activation and sen-
sitization, that finally culminate in a restricted activation of 
NLRP3 inflammasome. The results presented here may pro-
vide clues to better understand the molecular features that 
characterize the high IL-1β production found in patients with 
Majeed syndrome, and may open avenues for the development 
of new treatments that help to control or cure this condition.
MAterIALs And MetHods
reagents
LPS from Escherichia coli 0111:B4, the antibody against 
β-actin (A5441), SP600125, PD98059, and cholesterol-water 
 o
n
 D
ecem
ber 13, 2017
jem.rupress.org
D
ow
nloaded from
 
Lipin-2 regulates NLRP3 inflammasome | Lordén et al.524
soluble were obtained from Sigma-Aldrich. Antibodies against 
phospho-p38 MAPK (Thr180/Tyr182; 4511), p38 MAPK 
(9212), phospho-p44/42 MAPK (Thr202/Tyr204; 9101), 
p44/42 MAPK (4695), phospho-SAPK/JNK (Thr183/
Tyr185; 4668), SAPK/JNK (9252), and IL-1β (12242) were 
purchased from Cell Signaling Technology. Antibodies against 
ASC (22514), and active caspase-1 (sc-514 and 515) were 
obtained from Santa Cruz Biotechnology, Inc. Specific ON- 
Target plus siRNAs against murine mRNAs were obtained 
from Thermo Fisher Scientific. Silencer Select siRNAs spe-
cific to decrease the expression of human LPIN2 mRNA 
and negative controls were purchased from Ambion. Nigeri-
cine, the specific caspase-1 inhibitor Ac-YVAD-AOM, and 
SB203582 were purchased from EMD Millipore, and mono-
sodium urate and alum were obtained from InvivoGen. The 
general caspase inhibitor Z-VAD-FMK was from APExBIO. 
The rest of the reagents were purchased from Sigma-Aldrich.
Animals
The C57BL/6NLpin2tm1b(KOMP)Wtsi/Tcp mouse line deficient 
in lipin-2 (Lpin2−/−) was made by the NorCOMM2 Project 
from KOMP ES cells and provided by the Canadian Mouse 
Mutant Repository at the Toronto Centre for Phenogenom-
ics (Toronto, Canada). Untreated animals present increased 
red cell distribution width and thrombocytosis, and do not 
exhibit signs of osteomyelitis or systemic inflammation. This 
phenotype is concordant with that previously described by 
Dwyer et al. (2012). Animals were bred as heterozygotes at the 
Service of Animal Research and Welfare (University of Vall-
adolid, Valladolid, Spain) and maintained in filter-top cages 
and were provided with water and food ad libitum (Global 
diet 2014; Harlan). 8–12-wk-old sex-matched animals were 
used for experimentation and WT littermates were used as 
controls. For LPS treatment, animals were injected i.p. with 
10 mg/kg LPS in PBS. After 3 h, blood was collected from the 
facial vein and animals were euthanized for spleen and liver 
collection. All the protocols and procedures were approved by 
the Institutional Animal Care and Usage Committee and are 
in accordance with the Spanish and European Union guide-
lines for the use of experimental animals.
cells
Peritoneal macrophages were obtained, as previously de-
scribed (Meana et al., 2014), by flushing the peritoneal cavity 
with 5 ml ice-cold PBS. Cells were then centrifuged at 300 g 
for 10 min and allowed to adhere to glass coverslips overnight. 
Nonadherent cells were washed away with PBS and attached 
cells were maintained in culture until use.
BMDMs were differentiated from precursors ob-
tained from WT, Lpin2−/−, Asc−/− (Mariathasan et al., 2004), 
Casp1/11−/− (Kuida et al., 1995), and Nlrp3−/− (Marti-
non et al., 2006) mice femurs aseptically dislocated from 
the hind legs of the mice as previously described (Meana 
et al., 2014). In brief, isolated cells were cultured for 7 d in 
RPMI 1640 with 10% FBS, 100 U/ml penicillin, and 100 
µg/ml streptomycin, supplemented with 20% conditioned 
medium from L929 cells.
Human macrophages were differentiated from blood 
monocytes obtained from healthy donors as previously de-
scribed (Valdearcos et al., 2011) and lipin-2 levels were re-
duced using specific siRNAs from Ambion (sense sequence, 
5′-GAA GUU GGG UGA UAA CGG ATT-3′, and antisense 
sequence 5′-UCC GUU AUC ACC CAA CUU CAT-3′) in-
troduced in 10–14-d differentiated cells by Nucleofection 
(Amaxa Biosystems) as recommended by the manufacturers 
(Y-010 program). Usually, as much as 85–90% reduction of 
Lpin2 mRNA was achieved by this methodology after 2 d of 
macrophage transfection.
RAW264.7 cells were cultured in DMEM supple-
mented with 10% FBS, 2 mM l-glutamine, 100 U/ml penicil-
lin, and 100 µg/ml streptomycin. Lipin-2 levels were reduced 
using 20 nM ON-TAR GET plus SMA RT pool siRNAs 
(Thermo Fisher Scientific) introduced with Lipofectamine 
RNAiMAX (Thermo Fisher Scientific) as specified by the 
manufacturer. After 2 d of transfection, Lpin2 mRNA levels 
decreased 60–80% (Valdearcos et al., 2012).
eLI sA assays
Cell supernatants were clarified by centrifugation at 15,000 g 
for 10 min, and 100 µl were used for determinations. Mea-
surements to quantify TNF, IL1-β, and IL-18 were performed 
using specific ELI SA assays as detailed in manufacturer’s in-
structions (eBioscience).
Immunoblots
Cells were lysed with the buffer 20 mM Tris, pH 7.4, 150 mM 
NaCl, 1 mM EDTA, 1 mM EGTA, 5 mM Na4P2O7, 50 mM 
β-glycerophosphate, 270 mM sucrose, 0.1% 2-mercaptoeth-
anol, 1% Triton X-100, 100  µM PMSF, 1  mM Na3VO4, 
10 mM NaF, and a protease inhibitor cocktail (P-8340; Sig-
ma-Aldrich). Homogenates were centrifuged at 15,000 g for 
10 min, and 50–100 µg of supernatants protein were separated 
by standard SDS-PAGE and transferred to PVDF membranes. 
Blocking was performed with 5% defatted dry milk or 5% 
bovine serum albumin in PBS (pH 7.4) for 1 h at room tem-
perature. In general, primary antibodies were used at 1:1,000 
in PBS with 0.5% defatted dry milk and 0.1% Tween-20. The 
exceptions were anti-caspase-1, ASC, and β-actin that were 
used at 1:250, 1:500, and 1:20,000, respectively. After exten-
sive washes, secondary antibodies HRP linked were used at 
1:5,000 dilution. Specific proteins were visualized using ECL 
chemiluminescent substrate (GE Healthcare).
Proteins from cellular supernatants were clarified of 
cells by centrifugation at 300 g for 8 min at 4°C and were 
then concentrated by centrifugation at 15,000 g for 30 min 
at 4°C using a 10-kD centrifugal filter unit (EMD Millipore).
Asc oligomers
Analysis of ASC oligomers was done as previously described, 
with a few modifications (Chuang et al., 2013; Compan et 
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al., 2015). In brief, cells were lysed in the buffer 10 mM Tris-
HCl, pH 7.5, 10 mM NaCl, 3 mM MgCl2, 0.1 mM EGTA, 
100 µM Na3VO4, 1 mM PMSF, and a protease inhibitor cock-
tail (P-8340; Sigma-Aldrich) passed 30 times through a 21-
gauge syringe. Cell lysates were centrifuged at 5,200 g for 8 
min at 4°C to discard nuclei. Supernatants were diluted with 
equal volumes of buffer 20 mM Hepes-KOH, pH 7.5, 5 mM 
MgCl2, 0.5  mM EGTA, 0.1% CHA PS, and centrifuged at 
4,000 g for 8 min at 4°C to obtain the ASC oligomers. The 
pellets were then resuspended in the mentioned CHA PS buf-
fer with 2 mM disuccinimidyl suberate as a cross-linker. Re-
actions were incubated at room temperature for 30 min and 
centrifuged at 4,000 g for 10 min. Pelleted oligomers were 
analyzed by Immunoblot.
rt-qPcr
Total RNA was extracted using TRIzol reagent (Ambion). 
cDNA was obtained using RET ROscript kit Reverse Tran-
scription for RT-PCR (Thermo Fisher Scientific), following 
the manufacturer’s instructions. Quantitative real time-PCR 
analysis was performed in a LightCycler 480 (Roche) using 
specific primers, 40 ng cDNA, and the KAPA SYBR Master 
mix for RT-qPCR (Roche). Relative mRNA expression was 
obtained using the ΔΔCt method using Cyclophilin, actin, or 
Gapdh as reference genes (Livak and Schmittgen, 2001).
Primers used for murine genes were as follows: Lpin2, 
5′-AGT TGA CCC CAT CAC CGT AG-3′ and 5′-CCC AAA 
GCA TCA GAC TTG GT-3′; Il1b, 5′-GCA ACT GTT CCT 
GAA CTC AACT-3′ and 5′-TCT TTT GGG GTC CGT CAA 
CT-3′; Il18, 5′-CAA ACC TTC CAA ATC ACT TCCT-3′ 
and 5′-TCC TTG AAG TTG ACG CAA GA-3′; Nlrp3, 5′-
ATC AAC AGG CGA GAC CTC TG-3′ and 5′-GTC CTC 
CTG GCA TAC CAT AG-3′; Casp1, 5′-CTT GGA GAC ATC 
CTG TCA GGG-3′ and 5′-AGT CAC AAG ACC AGG CAT 
ATTC-3′; Il1r1, 5′-GTG CTA CTG GGG CTC ATT TG-3′ 
and 5′-GGA GTA AGA GGA CAC TTG CG-3′; Il6, 5′-TAG 
TCC TTC CTA CCC CAA TTT CC-3′ and 5′-TTG GTC 
CTT AGC CAC TCC TTC-3′; Tnf, 5′-ACG GCA TGG ATC 
TCA AAG AC-3′ and 5′-AGA TAG CAA ATC GGC TGA 
CG-3′; Il12b, 5′-TGG TTT GCC ATC GTT TTG CTG-3′ 
and 5′-ACA GGT GAG GTT CAC TGT TTCT-3′; Nos2, 5′-
CCA AGC CCT CAC CTA CTT CC-3′ and 5′-CTC TGA 
GGG CTG ACA CAA GG-3′; Il10, 5′-GCT CTT ACT GAC 
TGG CAT GAG-3′ and 5′-CGC AGC TCT AGG AGC ATG 
TG-3′; Ppib (Cyclofilin B), 5′-TGG AGA GCA CCA AGA 
CAG AC-3′ and 5′-TGC CGG AGT CGA CAA TGAT-3′; 
and Gapdh, 5′-AGG TCG GTG TGA ACG GAT TTG-3′ and 
5′-TGT AGA CCA TGT AGT TGA GGT CA-3′. Primers used 
for human genes were as follows: LPIN2, 5′-CCT CTC 
CTC AGA CCA GAT CG-3′ and 5′-GGA GAA TCT GTC 
CCA AAG CA-3′; IL1B, 5′-ATG ATG GCT TAT TAC AGT 
GGC AA-3′ and 5′-GTC GGA GAT TCG TAG CTG GA-
3′; IL18, 5′-TCT TCA TTG ACC AAG GAA ATC GG-3′ 
and 5′-TCC GGG GTG CAT TAT CTC TAC-3′; NLRP3, 
5′-CCA CAA GAT CGT GAG AAA ACCC-3′ and 5′-CGG 
TCC TAT GTG CTC GTCA-3′; CASP1, 5′-TTT CCG CAA 
GGT TCG ATT TTCA-3′ and 5′-GGC ATC TGC GCT 
CTA CCA TC-3′; IL1R1, 5′-ATG AAA TTG ATG TTC GTC 
CCT GT-3′ and 5′-ACC ACG CAA TAG TAA TGT CCTG-
3′; IL6, 5′-AAA TTC GGT ACA TCC TCG ACGG-3′ and 
5′-GGA AGG TTC AGG TTG TTT TCT GC-3′; TNF, 5′-
ATG AGC ACT GAA AGC ATG ATCC-3′ and 5′-GAG GGC 
TGA TTA GAG AGA GGTC-3′; and ACTB, 5′-CAT GTA 
CGT TGC TAT CCA GGC-3′ and 5′-CTC CTT AAT GTC 
ACG CAC GAT-3′. Primers used to study Lpin2 mRNA 
expression in cells from Lpin2−/− and WT mice were as 
follows: 5′-TTG GGT GAT AAT GGG GAG CC-3′ and 5′-
CTG AGC TGG CCT TTC ATT TC-3′.
electrophysiology
Cells were plated on 12-mm coverslips previously treated 
with poly-L-lysine (0.01 mg/ml) for 30 min. Patch micropi-
pettes were made from borosilicate glass (2.0 mm OD; WPI) 
and double pulled (Narishige) to resistances ranging from 5 
to 10 MΩ when filled with the internal solution contain-
ing 125  mM KCl, 4  mM MgCl2, 10  mM Hepes, 10  mM 
EGTA, and 5 mM MgATP, pH 7.2. Cells were bathed in an 
external solution containing 141 mM NaCl, 4.7 mM KCl, 
1.2 mM MgCl2, 1.8 mM CaCl2, 10 mM glucose, and 10 mM 
Hepes, pH 7.4. Cells were voltage-clamped at −80 mV. Ionic 
currents through P2X7R were recorded at room tempera-
ture using the whole-cell configuration of the patch-clamp 
technique. Current–voltage relationships were obtained with 
1s-ramp protocols from −120 mV to +100 mV applied every 
5 s, in control conditions or in the presence of ATP (2 mM) 
during 1 min. Whole-cell currents were recorded using an 
Axopatch 200A patch-clamp amplifier (Axon Instruments) 
filtered at 2 kHz (−3 dB, 4-pole Bessel filter) and sampled 
at 10 kHz. Recordings were digitized with a Digidata 1200, 
driven by CLA MPEX 10.2 software (Molecular Devices). 
Electrophysiological data analyses were performed using 
Clampfit subroutine of the pClamp software (Axon Instru-
ments) and with Origin 7 software (OriginLab Corporation). 
In most cases, current amplitude was corrected for cell size 
variations and expressed as current density (pA/pF), by divid-
ing for cell capacitance values.
K+ determinations
Intracellular K+ concentrations were quantified by optical 
emission spectrometry (Katsnelson et al., 2015). Cells were 
washed with the K+-free buffer: 135 mM sodium gluconate, 
1.5 mM CaCl2, 1 mM MgCl2, 25 mM Hepes, pH, 7.4. Cells 
were treated with 2 ml 10% nitric acid for 2 h, and extracted 
total K+ content was quantified using an inductively cou-
pled plasma/optical emission spectrometer (ICP/OES) Varian 
725-ES (VAR IAN Medical Systems, Inc.).
Flow cytometry
Cellular active caspase-1 content was assayed using the fluor-
escent inhibitor probe FAM-YVAD-FMK to label active 
 o
n
 D
ecem
ber 13, 2017
jem.rupress.org
D
ow
nloaded from
 
Lipin-2 regulates NLRP3 inflammasome | Lordén et al.526
caspase-1 (ImmunoChemistry Technologies) following the 
manufacturer’s instructions. In brief, FAM-YVAD-FMK was 
added to cells and incubated for 30 min at 37°C. After exten-
sive washes cell fluorescence was quantified by flow cytom-
etry in FL1 (Gallios; Beckman Coulter). Data were analyzed 
with the software Kaluza version 1.1.
PI uptake was analyzed by incubating cells with 50 
µg/ml PI in PBS in the dark for 5 min. Fluorescence was 
quantified by flow cytometry in FL3. Data were analyzed 
with Kaluza version 1.1.
ethidium bromide and Annexin V uptake
Cells on glass-bottom culture dishes (Matteck), were layered 
with 10 mM Hepes, pH 7.3, 149 mM NaCl, 0.8 mM KCl, 
0.6  mM CaCl2, 0.08  mM MgCl2, and 10  mM d-glucose, 
and imaged using an oil immersion, 63×, 1.4 NA, HCX PL 
APO CS objective in a confocal microscope at 37°C (TCS 
SP5X; Leica). Ethidium bromide (20 µM) was added 5 min 
before stimulation to establish a fluorescence base line, and 
images were taken at different time points. Fluorescence 
was excited at 548 nm using a Supercontinium laser and 
emission was collected over 560 nm. Fluorescence quan-
tification was performed using the ImageJ software (Na-
tional Institutes of Health).
For Annexin V uptake, cells were layered with a buffer 
consisting of 10 mM Hepes, 140 mM NaCl, 2.5 mM CaCl2, 
pH 7.4, to allow proper binding, and 1 µg/ml Annexin V-Cy3 
was added 5 min before stimulation. Images were taken every 
5 min, as mentioned for ethidium bromide.
Immunostaining
Cells plated over glass coverslips were stimulated, washed with 
PBS, and fixed with 4% paraformaldehyde and 3% sucrose 
for 20 min. Cells were then permeabilized with 0.1% Tri-
ton X-100 for 2 min and treated with PBS containing 0.5% 
BSA, 50 mM glycine, and 4% goat serum for 30 min at room 
temperature. Cells were then washed tree times and incu-
bated with antibodies against ASC diluted 1:50 in PBS plus 
0.1% BSA for 1 h. After washing, cells were incubated with 
Alexa Fluor 488-goat anti rabbit antibodies diluted 1:250 in 
PBS plus 0.1% BSA for 1 h. Cells were then washed treated 
with 1 µg/ml DAPI, washed again, and mounted using an 
antifade solution. Fluorescence was examined using an oil 
immersion, 63×, 1.4 NA, HCX PL APO CS objective in a 
Leica TCS SP5X confocal microscope. Alexa Fluor 488 was 
excited at 485 nm, and fluorescence emission was collected 
between 508 and 545 nm. DAPI fluorescence was excited 
with a blue diode at 405 nm and emission was collected 
between 439 and 475 nm.
cholesterol determinations
Total cellular cholesterol levels were measured as previously 
described with a few modifications (Zlatkis et al., 1953). Cells 
were washed with PBS, and sonicated in water twice for 
18 s. Protein concentration was then quantified. Lipids from 
lysates containing 1 mg protein were extracted with 5 vol of 
n -hexane :isopropanol (3:2; vol/vol). After centrifugation, the 
organic phase was recover, evaporated under N2 atmosphere, 
and resuspended in chloroform. Lipids were then treated with 
1 ml FeCl3 in glacial acetic acid (0.1 mg/ml). After vigorous 
agitation, the mix was centrifuged at 15,000  g for 1 min. 
Supernatants (0.5 ml) were mixed with 300 ml H2SO4 and 
allowed to react for 30 min, and then absorbance was measured 
at 560 nm in a spectrometer (VersaMax; Molecular Devices), 
and the concentration calculated using a standard curve.
cytotoxicity assay (LdH release)
Cells were stimulated and supernatants were collected and 
centrifuged at 300  g for 10 min. Supernatants were then 
assayed for LDH activity using a commercially available kit 
from Roche, following the manufacturer’s instructions. Ab-
sorbance from the product formazan was measured at 500 nm 
using a spectrophotometer.
ethics
Our study with human samples was approved by the Bioethics 
Committee of the Spanish National Research Council (CSIC) 
and the Ethics Committee of the University of Valladolid, in ac-
cordance with the guidelines established by the Spanish Minis-
try of Health and the European Union, in conformity with the 
World Medical Association Declaration of Helsinki. Human 
samples were provided by the Centro de Hemoterapia y He-
modonación de Castilla y León Biobank (Vallodolid, Spain). 
Written informed consent was obtained from each donor. The 
researchers received the samples in an anonymous manner.
statistics
Data are represented as mean ± SEM, or as mean ± SD. Sta-
tistical significance was determined by Student’s t test, or with 
one-way ANO VA followed by Tukey's test. P < 0.05 was con-
sidered statistically significant.
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